Short answer: the Rybelsus coupon still saves you money, just on a different pill. Novo Nordisk says Rybelsus is being replaced by the Ozempic pill, and anyone already signed up for a Rybelsus savings offer can keep using it on Ozempic without enrolling again.1
What changed
NovoCare's Rybelsus page now opens with one line: Rybelsus is being replaced by the Ozempic pill, and your health care provider will guide you through the change.1 Novo pairs the strengths like this:
| Rybelsus tablet | Ozempic pill |
|---|---|
| 3 mg | 1.5 mg |
| 7 mg | 4 mg |
| 14 mg | 9 mg |
Novo states the Ozempic tablets work similarly and have the same efficacy and safety as Rybelsus.1 Two practical points follow. You need a new prescription to move over, so this is a conversation with your prescriber, not a pharmacy swap. And Novo says the Ozempic pill will have the same coverage as Rybelsus, so an insured patient should not lose ground on the formulary.1 Which dose you move to is your prescriber's call; the pairing above is Novo's, not ours.
When we checked on 7 October 2026, the old Rybelsus savings-offer address on NovoCare opened the Ozempic savings offer instead.
The coupon itself
The terms are the ones Novo uses across its diabetes brands: pay as little as $25, with the saving capped at $100 a month, and government beneficiaries excluded.2 That cap is the part people miss. The card takes up to $100 off your copay; it lands you at $25 only when the copay was about $125 or less.
Because the Ozempic pill, like Rybelsus, is a type 2 diabetes drug, a commercial plan is far likelier to cover it than a weight-loss brand, which gives the card a copay to work on. If you already hold a Rybelsus offer, Novo says you do not have to sign up for a new one.1 More on the injectable side's card in the Ozempic coupon guide.
Paying without the card
Until now the awkward thing about this page was that Novo published no cash price for Rybelsus. The Ozempic pill has one: NovoCare Pharmacy lists self-pay options starting at $149 a month for people whose commercial plan does not cover it or who are uninsured, with the price set by dose.2 A self-pay fill runs outside your insurance, so it does not count toward a deductible or an out-of-pocket maximum.2
On Medicare or Medicaid, the savings card is closed to you.2 Novo's self-pay program is a separate thing: it says government-insured patients may use it if they pay themselves and process it outside their insurance, and that the purchase must not be counted toward Part D out-of-pocket totals (TrOOP).3 For most Medicare patients with type 2 diabetes, Part D coverage is still the cheaper route to try first.
Which route fits you
- Commercial insurance that covers it: the savings offer, against your copay.2
- Commercial insurance that does not cover it, or no insurance: the Ozempic pill's self-pay price at NovoCare Pharmacy.2
- Medicare: Part D for a diabetes indication first; Novo's self-pay outside insurance if that fails, knowing it will not count toward TrOOP.3
- Medicaid: diabetes coverage behind prior authorisation is the norm. Details here.
If you are not tied to the Ozempic pill specifically, the programs we track that sell oral semaglutide are below, cheapest first, at today's prices.
For the three semaglutide pills side by side, see Rybelsus and the newer semaglutide pills.
